1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial
Richard Hobbs, F D, Montgomery, Hugh, Padilla, Francisco, Kim, Kenneth, Simón Campos, Jesus Abraham, Arbetter, Douglas, Padilla, Kelly W, Reddy, Venkatesh P, Seegobin, Seth, Streicher, Katie, Viani, Rolando M, Koh, Gavin C KW, Esser, Mark T
Published in Open forum infectious diseases (15.12.2022)
Published in Open forum infectious diseases (15.12.2022)
Get full text
Journal Article